REGENXBIO Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Vasista Vittal | Chief Financial Officer | Option Exercise | 20,041 | $3.76 | $75,354 | 246,534 | Mar 19, 2024 |
| Mills Kenneth T. | President and CEO | Sale | 15,000 | $21.86 | $327,900 | 408,035 | Mar 14, 2024 |
| PAKOLA STEVE | Chief Medical Officer | Option Exercise | 12,878 | $22.25 | $286,536 | 120,070 | Mar 5, 2024 |
| Mills Kenneth T. | President and CEO | Sale | 4,652 | $16.47 | $76,618 | 418,383 | Feb 14, 2024 |
| Mills Kenneth T. | President and CEO | Sale | 45,000 | $15.18 | $683,100 | 408,035 | Jan 16, 2024 |
| Simpson Curran | Chief Oper. & Tech. Officer | Tax Withholding | 8,120 | $17.95 | $145,754 | 84,865 | Jan 2, 2024 |
| PAKOLA STEVE | Chief Medical Officer | Sale | 17,237 | $17.39 | $299,751 | 107,192 | Jan 2, 2024 |
| Vasista Vittal | Chief Financial Officer | Award / Grant | 16,026 | — | — | 226,493 | Jan 2, 2024 |
| Mills Kenneth T. | President and CEO | Award / Grant | 64,103 | — | — | 408,035 | Jan 2, 2024 |
| Christmas Patrick J. | Chief Legal Officer | Tax Withholding | 7,893 | $17.95 | $141,679 | 81,144 | Jan 2, 2024 |
| Mills Kenneth T. | President and CEO | Sale | 45,000 | $19.69 | $886,050 | 355,289 | Dec 19, 2023 |
| Danos Olivier | Chief Scientific Officer | Tax Withholding | 8,410 | $17.95 | $150,960 | 86,391 | Jun 30, 2023 |
| Fox Allan M. | — | Award / Grant | 3,486 | — | — | 6,496 | Jun 2, 2023 |
| Tasse Daniel | — | Award / Grant | 3,486 | — | — | 6,496 | Jun 2, 2023 |
| STUMP DAVID C | — | Award / Grant | 3,486 | — | — | 6,496 | Jun 2, 2023 |
| MIGAUSKY GEORGE V | — | Award / Grant | 3,486 | — | — | 6,496 | Jun 2, 2023 |
| Glucksmann Alexandra | — | Award / Grant | 3,486 | — | — | 6,496 | Jun 2, 2023 |
| KARABELAS ARGERIS N | — | Award / Grant | 3,486 | — | — | 6,496 | Jun 2, 2023 |
| Bennett Jean | — | Award / Grant | 3,486 | — | — | 6,496 | Jun 2, 2023 |
| Zachary Jennifer | — | Award / Grant | 3,486 | — | — | 9,506 | Jun 2, 2023 |
| Vasista Vittal | Chief Financial Officer | Option Exercise | 35,000 | $0.85 | $29,750 | 215,001 | May 31, 2023 |
| Vasista Vittal | Chief Financial Officer | Tax Withholding | 1,333 | $22.68 | $30,232 | 133,827 | Jan 3, 2023 |
| Simpson Curran | Chief Oper. & Tech. Officer | Award / Grant | 67,945 | — | — | 92,985 | Jan 3, 2023 |
| PAKOLA STEVE | Chief Medical Officer | Sale | 3,138 | $22.17 | $69,569 | 12,175 | Jan 3, 2023 |
| Mills Kenneth T. | President and CEO | Tax Withholding | 9,308 | $22.68 | $211,105 | 300,536 | Jan 3, 2023 |
| Danos Olivier | Chief Scientific Officer | Tax Withholding | 2,058 | $22.68 | $46,675 | 27,020 | Jan 3, 2023 |
| Christmas Patrick J. | Chief Legal Officer | Tax Withholding | 1,843 | $22.68 | $41,799 | 21,097 | Jan 3, 2023 |
| Vasista Vittal | Chief Financial Officer | Sale | 2,400 | $30.24 | $72,576 | 135,160 | Aug 30, 2022 |
| Vasista Vittal | Chief Financial Officer | Sale | 400 | $35.00 | $14,000 | 154,840 | Aug 5, 2022 |
| Vasista Vittal | Chief Financial Officer | Sale | 2,400 | $31.26 | $75,024 | 155,240 | Aug 1, 2022 |
| Vasista Vittal | Chief Financial Officer | Sale | 468 | $30.00 | $14,040 | 157,640 | Jul 13, 2022 |
| Zachary Jennifer | — | Award / Grant | 6,020 | — | — | 6,020 | Jun 3, 2022 |
| Tasse Daniel | — | Award / Grant | 3,010 | — | — | 3,010 | Jun 3, 2022 |
| STUMP DAVID C | — | Award / Grant | 3,010 | — | — | 3,010 | Jun 3, 2022 |
| MIGAUSKY GEORGE V | — | Award / Grant | 3,010 | — | — | 3,010 | Jun 3, 2022 |
| KARABELAS ARGERIS N | — | Award / Grant | 3,010 | — | — | 3,010 | Jun 3, 2022 |
| Glucksmann Alexandra | — | Award / Grant | 3,010 | — | — | 3,010 | Jun 3, 2022 |
| Fox Allan M. | — | Award / Grant | 3,010 | — | — | 3,010 | Jun 3, 2022 |
| Bennett Jean | — | Award / Grant | 3,010 | — | — | 3,010 | Jun 3, 2022 |
| Vasista Vittal | Chief Financial Officer | Option Exercise | 29,900 | $0.85 | $25,415 | 162,440 | Jan 20, 2022 |
| Vasista Vittal | Chief Financial Officer | Award / Grant | 8,900 | — | — | 132,540 | Jan 3, 2022 |
| Simpson Curran | Chief Oper. & Tech. Officer | Award / Grant | 10,700 | — | — | 27,116 | Jan 1, 2022 |
| PAKOLA STEVE | Chief Medical Officer | Sale | 1,598 | $33.75 | $53,933 | 8,250 | Jan 1, 2022 |
| Danos Olivier | Chief Scientific Officer | Award / Grant | 10,700 | — | — | 29,078 | Jan 1, 2022 |
| Christmas Patrick J. | Chief Legal Officer | Award / Grant | 7,900 | — | — | 22,940 | Jan 1, 2022 |
| Mills Kenneth T. | President and CEO | Award / Grant | 35,796 | — | — | 309,844 | Jan 1, 2022 |
| Fox Allan M. | — | Sale | 61,638 | $34.40 | $2,120,347 | 1,581,212 | Dec 23, 2021 |
| Mills Kenneth T. | President and CEO | Gift | 3,300 | — | — | 277,684 | Dec 2, 2021 |
| Mills Kenneth T. | President and CEO | Sale | 1,500 | $40.00 | $60,000 | 280,984 | Nov 8, 2021 |
| Mills Kenneth T. | President and CEO | Sale | 1,500 | $42.19 | $63,285 | 280,984 | Sep 27, 2021 |